DONNA VIAL: Open Payments
NPI 1306878186 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 39 payments from 10 companies in 2025. Trend: 2023 $751 · 2024 $584 · 2025 $906
Food & beverage: $811Education: $95
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $215 |
| GENZYME CORPORATION | 7 | $198 |
| ABBVIE INC. | 9 | $152 |
| Janssen Biotech, Inc. | 4 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| LEO Pharma Inc. | 2 | $41 |
| PFIZER INC. | 2 | $34 |
| REVANCE THERAPEUTICS, INC. | 1 | $33 |
| Incyte Corporation | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
Products named: DUPIXENT, TALTZ, TREMFYA, SKYRIZI, RINVOQ, SPEVIGO, ADBRY, CIBINQO.
Industry payments across LA — which companies pay providers there.
